comparemela.com

Latest Breaking News On - Antonio breast cancer symposium - Page 6 : comparemela.com

Greenwich LifeSciences, Inc.: Greenwich LifeSciences Provides Update on Phase III Clinical Trial, Flamingo-01

Greenwich LifeSciences, Inc.: Greenwich LifeSciences Provides Update on Phase III Clinical Trial, Flamingo-01
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

University-of-nebraska-medical-center
Nebraska
United-states
Baylor-university
Texas
University-of-miami
Florida
San-francisco
California
Salt-lake-city
Utah
Nevada

2024-02-14 | NDAQ:GLSI | Press Release | Greenwich Lifesciences Inc

(2024-02-14 | NDAQ:GLSI) Greenwich LifeSciences Provides Update on Phase III Clinical Trial, Flamingo-01

Texas
United-states
Madrid
Spain
Frankfurt
Brandenburg
Germany
Baylor-college-of-medicine
Hawaii
Winterhof
Nordrhein-westfalen
California

The Ongoing Investigation of GLSI-100 Continues in the Flamingo-01 Study for HER2/Neu+ Breast Cancer

The ongoing Flamingo-01 trial continues to investigate GLSI-100 in HER2/neu-positive breast cancer following various holds.

San-antonio
Texas
United-states
Spain
Italy
Germany
Poland
France
Baylor-college-of-medicine
Houston
Mothaffarf-rimawi
Danl-duncan

BLOG: 'Exciting' discoveries at oncology conferences not always accessible to everyone

BLOG: 'Exciting' discoveries at oncology conferences not always accessible to everyone
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

San-antonio
Texas
United-states
Mexico
Mexico-city
Distrito-federal
Mexican
Haydee-verduzco-aguirre
Daiichi-sankyo
Astrazeneca
Antonio-breast-cancer-symposium
Medication-book

McAndrews Expands on the Evolving Treatment Armamentarium in HER2+ Breast Cancer

Nicholas P. McAndrew, MD, MSCE, discusses how updated clinical trial findings are shifting the treatment paradigm in HER2-positive metastatic breast cancer.

San-antonio
Texas
United-states
California
Los-angeles
Nicholasp-mcandrew
David-geffen-school-of-medicine
University-of-california
Antonio-breast-cancer-symposium
Science-summit
Geffen-school

vimarsana © 2020. All Rights Reserved.